A communication from the Massachusetts Department of Transportation (see item 1595-6369 of Section 2E of Chapter 9 of the Acts of 2025) regarding the MBTA’s Naxolone (Narcan) Pilot Distribution Program

This bill (HD 5349) is a procedural communication from the Massachusetts Department of Transportation about the MBTA's pilot program distributing Naloxone (Narcan), an opioid overdose reversal medication. It does not create new law but formally references the program's implementation details (item 1595-6369 in Chapter 9 of the 2025 Acts). The bill directly affects MBTA staff managing the pilot and potentially transit riders who could access the medication through the program. It serves as an administrative update, not a policy change.